Showing 201-220 out of 19658 hits
| Metabolite |
Normal Concentration Range (µmol/L) |
Abnormal Concentration Range (µmol/L) |
Condition Associated with Abnormal Concentration Range or Specificity of Normal Range |
Age (Gender) |
Reference |
4-Trimethylammoniobutanoic acid HMDB01161
Confirmed |
| 10.0 (0.5-20.0) | | Normal |
Adult:>18_yrs_old (Both) |
15164354 |
|
4a-Carbinolamine tetrahydrobiopterin HMDB02215
Confirmed |
| 4.18 +/- 0.04 | | Normal |
Adult:>18_yrs_old (Male) |
8376528 |
|
5'-Hydroxycarvedilol HMDB13948
Probable | |
5'-Hydroxylornoxicam HMDB13991
Probable | |
5'-Hydroxypiroxicam HMDB14096
Probable | |
5'-Hydroxytenoxicam HMDB14098
Probable | |
5'-O-Desmethyl omeprazole HMDB14011
Probable | |
5,10-Methylene-THF HMDB01533
Confirmed |
| 0.01 (0.0-0.21) | | Normal |
Adult:>18_yrs_old (Both) |
18160726 |
|
5,15-DiHETE HMDB10216
Confirmed |
| 0.000247 +/- 0.0000200 | | Normal |
Adult:>18_yrs_old (N/A) |
18953024 |
| 0.000527 +/- 1.7E-5 | | Normal |
Adult:>18_yrs_old (Both) |
20671299 |
| 0.247 +/- 0.02 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
| <0.07 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
|
5,6-DHET HMDB02343
Confirmed |
| 0.000438 +/- 0.000245 | | Normal |
Adult:>18_yrs_old (N/A) |
Oxygenated lipids were quantified by Theresa L. Pedersen and John W. Newman at the USDA’s Western Human Nutrition Research Center, Davis, CA, and Lipomics Technologies, Inc. |
| 0.00061 +/- 5.7E-5 | | Normal |
Adult:>18_yrs_old (Both) |
20671299 |
| 0.264 +/- 0.025 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
| 0.189 +/- 0.092 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
|
5,6-Epoxy-8,11,14-eicosatrienoic acid HMDB02190
Confirmed |
| 0.00011 +/- 2.1E-5 | | Normal |
Adult:>18_yrs_old (Both) |
20671299 |
| 0.00700 +/- 0.00982 | | Normal |
Adult:>18_yrs_old (Both) |
21359215; 18953024 |
|
5,8,11-Eicosatrienoic acid HMDB10378
Confirmed |
| 0.012 +/- 2.910 | | Normal |
Adult:>18_yrs_old (Both) |
20671299 |
| 0.987 +/- 0.45 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
| 1.316 +/- 1.365 | | Normal |
Adult:>18_yrs_old (Both) |
18953024 |
|
5-Aminoimidazole-4-carboxamide HMDB03192
Confirmed |
| 5.55 (0.79 - 39.67) | Malignant melanoma or sarcoma |
Adult:>18_yrs_old (Both) |
7172404 |
|
5-Aminolevulinic acid HMDB01149
Confirmed | |
5-HEPE HMDB05081
Confirmed |
| 0.00067 +/- 0.000121 | | Normal |
Adult:>18_yrs_old (Both) |
20671299 |
| 0.000863 +/- 0.000404 | | Normal |
Adult:>18_yrs_old (N/A) |
18953024 |
| 1.15 +/- 0.14 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
| 0.228 +/- 0.091 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
|
5-HETE HMDB11134
Confirmed |
| 0.001598 +/- 0.000958 | | Normal |
Adult:>18_yrs_old (Both) |
18953024; 21359215 |
| 0.0119 +/- 0.0014 | | Normal |
Adult:>18_yrs_old (Both) |
20671299 |
| 0.901 +/- 0.029 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
| 1.02 +/- 0.79 | | Normal |
Adult:>18_yrs_old (N/A) |
21359215 |
| 1.605 +/- 0.209 | Asthma |
Adult:>18_yrs_old (Both) |
10361015 |
| 0.159 +/- 0.037 | | Normal (stimulation with calcium ionophore A23187) |
Adult:>18_yrs_old (Both) |
10361015 |
| 0.07 +/- 0.02 | | Normal plasma |
Adult:>18_yrs_old (Both) |
3432563 |
| 0.25 +/- 0.09 | | Normal serum |
Adult:>18_yrs_old (Both) |
3432563 |
| 0.600 +/- 0.097 | Rheumatoid arthritis |
Adult:>18_yrs_old (Both) |
10361015 |
| 0.787 +/- 0.056 | Rhinitis patients |
Adult:>18_yrs_old (Both) |
10361015 |
| 3.51 +/- 0.57 | Serum stimulated with 2 mM arachidonic acid and 25 uM A23187 to maximize HETE production |
Adult:>18_yrs_old (Both) |
3432563 |
|
5-Hydroxy-L-tryptophan HMDB00472
Confirmed |
| 0.018 +/- 0.0027 | | Normal |
Adult:>18_yrs_old (Both) |
11910264 |
|
5-Hydroxyfluvastatin HMDB14039
Probable | |
5-Hydroxyindoleacetic acid HMDB00763
Confirmed |
| 0.0516 +/- 0.0068 | | Normal |
Adult:>18_yrs_old (Both) |
2480613 |
| 0.0449 +/- 0.0140 | Schizophrenia |
Adult:>18_yrs_old (Female) |
2480613 |
|
5-Hydroxyketamine HMDB14016
Probable | |